Irena Arandjelovic

Prof. Dr. Irena Arandjelovic

Institute of Microbiology and Immunology, University of Belgrade- Faculty of Medicine, Belgrade, Beograd, Serbia
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 December 2019 in Wellcome Open Research
Verified
Journal Article
Open access
PDF file
MHMartin Hunt
Martin Hunt
PBPhelim Bradley
Phelim Bradley
Simon Grandjean LapierreSimon Grandjean Lapierre
Simon Grandjean Lapierre
SHSimon Heys
Simon Heys
MTMark Thomsit
Mark Thomsit
ZIZamin Iqbal
Zamin Iqbal
Two billion people are infected with Mycobacterium tuberculosis, leading to 10 million new cases of active tuberculosis and 1.5 million deaths annually. Universal access to drug susceptibility testing (DST) has become a World Health Organization priority. We previously developed a software tool, Mykrobe predictor, which provided offline species identification and drug resistance predictions for M. tuberculosis from whole genome sequencing (WGS) data. Performance was insufficient to support the use of WGS as an alternative to conventional phenotype-based DST, due to mutation catalogue limitations. Here we present a new tool, Mykrobe, which provides the same functionality based on a new software implementation. Improvements include i) an updated mutation catalogue giving greater sensitivity to detect pyrazinamide resistance, ii) support for user-defined resistance catalogues, iii) improved identification of non-tuberculous mycobacterial species, and iv) an updated statistical model for Oxford Nanopore Technologies sequencing data. Mykrobe is released under MIT license at https://github.com/mykrobe-tools/mykrobe. We incorporate mutation catalogues from the CRyPTIC consortium et al. (2018) and from Walker et al. (2015), and make improvements based on performance on an initial set of 3206 and an independent set of 5845 M. tuberculosis Illumina sequences. To give estimates of error rates, we use a prospectively collected dataset of 4362 M. tuberculosis isolates. Using culture based DST as the reference, we estimate Mykrobe to be 100%, 95%, 82%, 99% sensitive and 99%, 100%, 99%, 99% specific for rifampicin, isoniazid, pyrazinamide and ethambutol resistance prediction respectively. We benchmark against four other tools on 10207 (=5845+4362) samples, and also show that Mykrobe gives concordant results with nanopore data. We measure the ability of Mykrobe-based DST to guide personalized therapeutic regimen design in the context of complex drug susceptibility profiles, showing 94% concordance of implied regimen with that driven by phenotypic DST, higher than all other benchmarked tools.

13 March 2020 in Molecular Biology and Evolution
Verified
Journal Article
Open access
DWDaniel J Wilson
Daniel J Wilson
TCThe CRyPTIC Consortium
The CRyPTIC Consortium
DCDerrick W Crook
Derrick W Crook
TPTimothy E A Peto
Timothy E A Peto
AWA Sarah Walker
A Sarah Walker
DSDick van Soolingen
Dick van Soolingen
The dN/dS ratio provides evidence of adaptation or functional constraint in protein-coding genes by quantifying the relative excess or deficit of amino acid-replacing versus silent nucleotide variation. Inexpensive sequencing promises a better understanding of parameters, such as dN/dS, but analyzing very large data sets poses a major statistical challenge. Here, I introduce genomegaMap for estimating within-species genome-wide variation in dN/dS, and I apply it to 3,979 genes across 10,209 tuberculosis genomes to characterize the selection pressures shaping this global pathogen. GenomegaMap is a phylogeny-free method that addresses two major problems with existing approaches: 1) It is fast no matter how large the sample size and 2) it is robust to recombination, which causes phylogenetic methods to report artefactual signals of adaptation. GenomegaMap uses population genetics theory to approximate the distribution of allele frequencies under general, parent-dependent mutation models. Coalescent simulations show that substitution parameters are well estimated even when genomegaMap’s simplifying assumption of independence among sites is violated. I demonstrate the ability of genomegaMap to detect genuine signatures of selection at antimicrobial resistance-conferring substitutions in Mycobacterium tuberculosis and describe a novel signature of selection in the cold-shock DEAD-box protein A gene deaD/csdA. The genomegaMap approach helps accelerate the exploitation of big data for gaining new insights into evolution within species.

21 November 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
IDIvana Dakić
Ivana Dakić
Irena ArandjelovicIrena Arandjelovic
Irena Arandjelovic
BSBranislava Savić
Branislava Savić
SJSnežana Jovanović
Snežana Jovanović
MTMirjana Tošić
Mirjana Tošić
DVDragana Miroslav Vukovic
Dragana Miroslav Vukovic
The rates of pulmonary colonization and disease due to nontuberculous mycobacteria (NTM) appear to be increasing globally, but diversity of species recovered as well as clinical relevance of NTM isolates differ considerably by geographic region. The first nationwide study of isolation frequency and clinical significance of NTM in Serbia included all patients with respiratory specimens yielding a positive NTM culture over the six-year period, 2010–2015. We analyzed trends in annual NTM isolation and NTM pulmonary disease (PD) incidence rates, with NTM PD cases defined in accordance with microbiological criteria established by the American Thoracic Society/Infectious Diseases Society of America (ATS/IDSA). 777 pulmonary NTM isolates were collected from 565 patients, of whom 126 (22.3%) met the ATS/IDSA criteria. The annual NTM isolation and NTM PD incidence rates per 100,000 changed over 2010–2015 from 0.9 to 1.6 (p = 0.1746) and from 0.18 to 0.48 (p = f0.0040), respectively. Both isolation and disease rates increased considerably with age, while higher NTM PD rates were also associated with residence in urbanized areas. Diversity of NTM species isolated was shown to be region-specific, with M. xenopi as the most prevalent species (17.3%), and increasing isolation rates of rapid growing mycobacteria (RGM) (p = 0.0072). M. xenopi was also the most common cause of NTM PD (28.6%), followed by RGM (27.8%). With 73% clinically relevant isolates, M. abscessus was identified as the most clinically relevant NTM species. While NTM PD obviously remains a rare disease in Serbia, the overall results justify recognition of NTM as pathogens of rising importance, and require further characterization of their epidemiology in the country.

30 October 2021 in Arabian Journal of Chemistry
Verified
Journal Article
Open access
MAMohamed H. Assaleh
Mohamed H. Assaleh
SBSnezana K. Bjelogrlic
Snezana K. Bjelogrlic
NPNevena Prlainovic
Nevena Prlainovic
ICIlija Cvijetic
Ilija Cvijetic
ABAleksandra Bozic
Aleksandra Bozic
AMAleksandar Marinkovic
Aleksandar Marinkovic
A series of twelve novel hybrids of cinnamic acid and thiocarbohydrazones were designed, synthesized in high yield using a simple coupling strategy via acid chlorides, and evaluated for their impact against Mycobacterium tuberculosis (Mtb) and cancer cells survival. Among them, compound 3 demonstrated strong anti-Mtb activity by reducing bacilli survival for>90 % in all three treated Mtb isolates, whereas isoniazid and rifampicin did not. Moreover, compound 3 didn’t affect vitality of HepG-2 cells, implying on advantageous hepatotoxicity profile compared to current therapeutic options for tuberculosis. Compounds 2a and 3b displayed as strong inducers of apoptosis in A549 cells, both activating intrinsic caspase pathway and cell cycle arrest at the G0/G1 phase. Subsequent analyses disclosed differences in their activities, where 3b has ability to induce production of mitochondrial superoxide anions, while 2a significantly inhibited cellular mobility. More importantly, 3b considerably affected viability of HepG-2 and HaCaT cells, whereas 2a had moderate impact only on the later. Molecular modeling studies indicated high permeability and good absorption through the human intestine, and moderate aqueous solubility with poor blood–brain barrier permeability. In summary, our results reveal that novel compounds 3 and 2a represent promising agents for tuberculosis and cancer treatment, respectively, indicating that further investigation needs to be performed to clarify the mechanisms of their anti-Mtb and anticancer activity.

1 March 2019 in Emerging Infectious Diseases
Verified
Journal Article
Open access
Irena ArandjelovicIrena Arandjelovic
Irena Arandjelovic
MMMatthias Merker
Matthias Merker
ERElvira Richter
Elvira Richter
TKThomas A. Kohl
Thomas A. Kohl
BSBranislava Savić
Branislava Savić
Stefan NiemannStefan Niemann
Stefan Niemann
A retrospective population-based molecular epidemiologic study of multidrug-resistant Mycobacterium tuberculosis complex strains in Serbia (2008–2014) revealed an outbreak of TUR genotype strains in a psychiatric hospital starting around 1990. Drug unavailability, poor infection control, and schizophrenia likely fueled acquisition of additional resistance and bacterial fitness–related mutations over 2 decades.

20 August 2024 in Applied Sciences
Verified
Journal Article
Open access
PDF file
ARAndrea Radalj
Andrea Radalj
ANAleksandar Nikšić
Aleksandar Nikšić
JTJelena Trajkovic
Jelena Trajkovic
TKTara Knezevic
Tara Knezevic
MJMarko Jankovic
Marko Jankovic
PKPredrag Kolarz
Predrag Kolarz
Airborne pathogens, though a minor fraction of airborne particles, can cause infections, intoxications, or allergic reactions through respiration, dermal contact, or ingestion. The SARS-CoV-2 pandemic has underscored the significance of mitigating airborne microbial threats. Traditional air ionization methods, such as dielectric barrier discharge and metal tip corona discharge, produce ozone, a reactive and potentially harmful byproduct. However, carbon-fiber ionizers (CFIs) generate high concentrations of ions with minimal ozone production, making them a safer alternative. Operating at voltages below 5 kV, CFIs are more efficient than their metallic counterparts. This review focuses on the antimicrobial efficacy of CFIs, which produce unipolar ions that can disrupt microbial membranes, leading to cell death. Compared to ultraviolet light sterilization, CFIs are cost-effective and suitable for small spaces. The literature review highlights the need for comprehensive studies to evaluate the real-world application and effectiveness of CFIs. Many existing studies are limited by small-scale testing and insufficient data reporting, complicating comparative analyses. Our work aims to provide a detailed perspective on CFIs, examining their impact on various microorganisms, ion efficacy, ionization outcomes, and ozone generation levels. By addressing these aspects, the review seeks to offer an updated understanding of CFIs’ antimicrobial capabilities and to identify limitations in current research, paving the way for more informed and effective air purification strategies.